LeMaitre Vascular to Present at Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting at four conferences in November.
David Roberts, President, is scheduled to present at the Stifel Healthcare Conference on Tuesday, November 13, 2018 at the Lotte New York Palace Hotel in New York City. The Company’s presentation is scheduled to begin at 4:15 PM EST.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Jefferies London Healthcare Conference on Wednesday, November 14, 2018 at the Waldorf Hilton Hotel in London, UK. The Company’s presentation is scheduled to begin at 5:20 PM UTC/GMT.
Steven Chehames, Investor Relations, is scheduled to present at the Southwest IDEAS Investor Conference on Wednesday, November 14, 2018 at the Fairmont Hotel in Dallas, TX. The Company’s presentation is scheduled to begin at 1:10 PM CST.
George LeMaitre, Chairman & CEO, is scheduled to present at the Cannacord Genuity Medical Technologies & Diagnostics Forum on Thursday, November 15, 2018 at the Westin Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 9:00 AM EST.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company’s diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.Investor Relations Steven Chehames+1-781-425-1659 firstname.lastname@example.org